MedTrace Logo

WALANT in Distal Radius Fracture Osteosynthesis

NCT05421000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2022-06-16

No results posted yet for this study

Summary

The purpose of this study is to assess the applicability and potential benefits of Wide Awake Local Anesthesia No Tourniquet (WALANT) or Local Anesthesia No Tourniquet ("LANT) versus locoregional anesthesia (LRA) and tourniquet in osteosynthesis of distal radius fractures (DRF) during the immediate postoperative period. Our hypothesis is that being able to avoid the use of a limb tourniquet in such a procedure may cause less swelling and better surgical wound appearance in the immediate postoperative period, without compromising pain level, patient satisfaction, or improving the number of complications. In this regard, prospective randomized study was designed comparing short term results of patients who were operated using WALANT (A) to locoregional anesthesia (LRA) and tourniquet (B). Main outcomes were pain, swelling and patient satisfaction. Surgical wound bleeding,mobility, surgeon's technical difficulty, insufficient anesthesia and complications were also evaluated.

Conditions

  • Radius Fracture Distal

Interventions

PROCEDURE

WALANT

Wide awake local anesthesia without tourniquet for distal radius fracture surgery

PROCEDURE

Locoregional anesthesia and tourniquet

Locoregional anesthesia and tourniquet for distal radius fracture surgery

Sponsors & Collaborators

  • Institut de Recerca Biomèdica de Lleida

    collaborator OTHER

  • Hospital Arnau de Vilanova

    lead OTHER

Principal Investigators

  • Ana Scott-Tennent, Miss · Hospital Arnau Vilanova

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-20
Primary Completion
2021-12-22
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421000 on ClinicalTrials.gov